Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PegIFN α-2b in Inactive Hepatitis B Carriers
NCT05451420Completed
- Sponsor
- Henan Provincial People's Hospital
- Start
- Dec 2017
- Primary completion
- Jun 2020
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
Randomised, open-label trial of peginterferon alfa-2b in Chronic Hepatitis B (CHB), sponsored by Henan Provincial People's Hospital. Started Dec 2017; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT05451420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05451420.